🇺🇸 FDA
Pipeline program

vistusertib (AZD2014)

2017-01-003

Phase 2 small_molecule terminated

Quick answer

vistusertib (AZD2014) for Small Cell Lung Cancer is a Phase 2 program (small_molecule) at Samsung Bioepis NL B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Samsung Bioepis NL B.V.
Indication
Small Cell Lung Cancer
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials